Advanced Solid Tumor
Showing NaN - NaN of 50
Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
-
Los Angeles, California
- +5 more
Sep 12, 2023
Advanced Solid Tumor Trial in United Kingdom (RP3, Nivolumab)
Recruiting
- Advanced Solid Tumor
- RP3
- Nivolumab
-
Houston, Texas
- +6 more
Jan 30, 2023
Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)
Recruiting
- Cancer
- +4 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 24, 2023
Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)
Active, not recruiting
- Advanced Solid Tumor
- Metastatic Breast Cancer
-
Gilbert, Arizona
- +19 more
Jan 13, 2023
Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)
Recruiting
- Advanced Solid Tumor
- Malignant Solid Tumor
-
Los Angeles, California
- +21 more
Jan 5, 2023
Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)
Recruiting
- Advanced Solid Tumor
- BRAF V600 Mutation
-
San Francisco, California
- +3 more
Dec 30, 2022
Advanced Solid Tumor Trial in Korea, Republic of, United States (hSTC810)
Recruiting
- Advanced Solid Tumor
- hSTC810
-
New Haven, Connecticut
- +4 more
Nov 16, 2022
KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)
Active, not recruiting
- KRAS Mutation-Related Tumors
- +2 more
-
Los Angeles, California
- +5 more
Nov 7, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)
Recruiting
- Advanced Solid Tumor
- Cutaneous T-cell Lymphoma (CTCL)
-
Detroit, Michigan
- +5 more
Oct 6, 2022
Advanced Solid Tumor Trial in United States (Nemvaleukin alfa, Pembrolizumab)
Recruiting
- Advanced Solid Tumor
- Nemvaleukin alfa
- Pembrolizumab
-
Grand Rapids, Michigan
- +3 more
Aug 30, 2022
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022